Yonsei University

This study is observing how well a new type of heart stent works for people with long blockages in their coronary arteries. The stent is designed to release medication without using a polymer coating. Researchers will follow 300 patients to check if the stent is safe and effectiv…

This study compares two powerful combinations of cholesterol-lowering drugs for people who have had a heart stent placed. Researchers want to see which combination helps more patients keep their 'bad' cholesterol very low and which one causes fewer side effects, so patients are m…

This study is testing whether a new combination of treatments can better shrink tumors before surgery for head and neck cancers caused by HPV. It is for patients with advanced but operable cancer who have not had prior treatment. The goal is to see if adding a vaccine and other i…

This study is testing a three-drug combination (Lazertinib, Pemetrexed, and Carboplatin) for people with a specific type of advanced non-small cell lung cancer. It is for patients whose cancer has started growing again after being treated with the drug Lazertinib alone. The main …

This study looks at whether a common type of diabetes medication (SGLT2 inhibitors) helps prevent future heart problems in people who have both diabetes and a recent heart attack. Researchers will analyze health records from 200,000 patients in Korea to compare outcomes between t…

This study is testing if giving an immunotherapy drug called durvalumab before and after surgery can help control non-small cell lung cancer. It involves 25 patients with operable cancer. The main goal is to see how much the drug shrinks the tumor before it is removed and to unde…

This study is testing a drug called T-DXd (Trastuzumab deruxtecan) for people with a specific type of advanced lung cancer that has spread to the brain. The main goal is to see how well the drug can delay the growth of cancer in the brain. It will also monitor for serious side ef…

This study aims to find better ways to predict which patients with advanced head and neck cancer will benefit from the immunotherapy drug nivolumab. Researchers will analyze blood and tumor samples from 50 patients to look for biological markers linked to treatment success. The g…